[1]
2020. An analytical study of iboga alkaloids contained in Tabernanthe iboga-derived products offered by ibogaine treatment providers. Archives of Clinical Psychiatry. 47, 2 (Apr. 2020), 51–54. DOI:https://doi.org/10.1590/0101-60830000000231.